Latest articles for Heartburn/Acid Reflux
Conference Coverage
Shorter H pylori Treatment With Vonoprazan Shows Better Results
The triple therapy regimen with vonoprazan was generally better tolerated than the 14-day omeprazole-based regimen.
Latest News
No Link Between PPI Use and Risk for Cardiovascular Events
Patients with gastroesophageal reflux disease do experience a slight increase in cardiovascular events with PPI use, the researchers noted.
Conference Coverage
Cendakimab That Targets IL-13 Shows Promise in Eosinophilic Esophagitis
Treatment with cendakimab also improved key endoscopic and histologic features, even in patients who had an inadequate response or intolerance to...
From the Journals
Acid Blockers Appear Superior to PPIs in Erosive Esophagitis
Both potassium-competitive acid blockers and PPIs showed better healing rates at 4 and 8 weeks than placebo.
News from the FDA/CDC
FDA OKs Voquezna for Heartburn Relief in Nonerosive Gastroesophageal Reflux Disease
The approval in nonerosive GERD was supported by results of the PHALCON-nonerosive GERD-301 study.
Latest News
Gene Tests Could Predict if a Drug Will Work for a Patient
Pharmacogenetics could help physicians determine which patients would and would not benefit from medications.
Latest News
Menopause, RSV, and More: 4 New Meds to Know
New treatments have been approved to treat conditions including GERD, depression, RSV vaccines, and hot flashes with menopause.
Latest News
Erosive Esophagitis: 5 Things to Know
Physician shares risk factors, potential therapies, and complications of EE.
Latest News
How Does Diet Affect Gastroesophageal Reflux Disease?
Diets low in fats and carbohydrates should be recommended as producing the fewest GERD symptoms.
From the Journals
Swallow this: Tiny tech tracks your gut in real time
Part of what makes gastrointestinal troubles so frustrating are the invasive and uncomfortable tests one must endure for diagnosis.